首页> 外文OA文献 >Parental LTRs Are Important in a Construct of a Stable and Efficient Replication-Competent Infectious Molecular Clone of HIV-1 CRF08_BC
【2h】

Parental LTRs Are Important in a Construct of a Stable and Efficient Replication-Competent Infectious Molecular Clone of HIV-1 CRF08_BC

机译:父母LTR在稳定和有效的具有复制能力的HIV-1 CRF08_BC复制能力的感染分子克隆中很重要。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Circulating recombinant forms (CRFs) of HIV-1 have been identified in southern China in recent years. CRF08_BC is one of the most predominant subtypes circulating in China. In order to study HIV subtype biology and to provide a tool for biotechnological applications, the first full-length replication-competent infectious molecular clone harboring CRF08_BC is reported. The construction of this clone pBRGX indicates that a moderate-copy number vector is required for its amplification in E. coli. In addition, it is shown that the parental CRF08_BC LTRs are important for generating this efficient replication-competent infectious clone. These observations may aid in the construction of infectious clones from other subtypes. Both the pBRGX-derived virus and its parental isolate contain CCR5 tropism. Their full-length genomes were also sequenced, analyzed, compared and deposited in GenBank (JF719819 and JF719818, respectively). The availability of pBRGX as the first replication-competent molecular clone of CRF08_BC provides a useful tool for a wide range of studies of this newly emergent HIV subtype, including the development of HIV vaccine candidates, antiviral drug screening and drug resistance analysis.
机译:近年来,在中国南部已经发现了HIV-1的循环重组形式(CRF)。 CRF08_BC是中国流行的最主要的亚型之一。为了研究HIV亚型生物学并提供用于生物技术应用的工具,报道了第一个具有CRF08_BC的具有全长复制能力的传染性分子克隆。该克隆pBRGX的构建表明在大肠杆菌中扩增需要中等拷贝数的载体。另外,已经表明,亲本CRF08_BC LTR对于产生这种有效的具有复制能力的传染性克隆很重要。这些观察结果可能有助于构建其他亚型的感染性克隆。 pBRGX衍生的病毒及其亲本分离物均含有CCR5向性。还对它们的全长基因组进行了测序,分析,比较并保存在GenBank中(分别为JF719819和JF719818)。作为第一个具有复制能力的CRF08_BC分子克隆,pBRGX的可用性为这一新出现的HIV亚型的广泛研究提供了有用的工具,包括开发HIV候选疫苗,抗病毒药物筛选和耐药性分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号